Eric N. Churchill

2.2k citations

26 papers · 1.8k indexed · 1 hit paper · h-index 17

Molecular Biology top 10%
Pathology and Forensic Medicine top 2%
Cardiology and Cardiovascular Medicine top 5%
Physiology top 10%
Epidemiology

Co-authors: Daria Mochly‐Rosen Marie‐Hélène Disatnik Grant R. Budas Che-Hong Chen Thomas D. Hurley Luke I. Szweda Christopher L. Murriel Alice Vallentin
Topics: Cardiac Ischemia and Reperfusion (7 papers)Lung Cancer Treatments and Mutations (7 papers)Mitochondrial Function and Pathology (5 papers)
Cited by: Pathology and Forensic Medicine Biochemistry Cardiology and Cardiovascular Medicine
Journals: Science Journal of Biological Chemistry Circulation
Partner nations: United States China Brazil

In The Last Decade

Eric N. Churchill

25 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the Heart

2008 632 citations Che-Hong Chen, Grant R. Budas et al. profile →

Peers

Countries citing papers authored by Eric N. Churchill

Since Specialization

Citations

This map shows the geographic impact of Eric N. Churchill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric N. Churchill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric N. Churchill more than expected).

Fields of papers citing papers by Eric N. Churchill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric N. Churchill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric N. Churchill. The network helps show where Eric N. Churchill may publish in the future.

Co-authorship network of co-authors of Eric N. Churchill

This figure shows the co-authorship network connecting the top 25 collaborators of Eric N. Churchill. A scholar is included among the top collaborators of Eric N. Churchill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric N. Churchill. Eric N. Churchill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patterns of Treatment and Real‐World Outcomes of Patients With Non‐small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations Receiving Mobocertinib: The EXTRACT Study 2025 ·Cancer Medicine ·Geoffrey Liu,(unknown),Tony Mok,(unknown),Alexis B. Cortot,(unknown),R. Descourt,(unknown),Parneet Cheema,James M. Gwinnutt,Eric N. Churchill,(unknown),Eileen Curran,Alexandra Savell,Yu Yin,Kelly K. Chong,(unknown),(unknown),Jacques Cadranel	0
2	EP.12B.02 Real-World Treatment Patterns and Effectiveness in Patients with ALK+ Advanced NSCLC Treated with 1L ALK TKIs 2024 ·Journal of Thoracic Oncology ·(unknown),(unknown),(unknown),(unknown),You Wu,(unknown),Cristina Farriols Danés,Eric N. Churchill,Anastasios Dimou	1
3	585P Real-world outcomes in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations receiving mobocertinib 2023 ·Annals of Oncology ·Tony Mok,Geoffrey Liu,(unknown),(unknown),Alexis B. Cortot,(unknown),R. Descourt,(unknown),Parneet Cheema,(unknown),Eric N. Churchill,(unknown),(unknown),(unknown),Kelly K. Chong,(unknown),(unknown),Jacques Cadranel	1
4	Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLC 2023 ·Journal of Thoracic Oncology ·Sai‐Hong Ignatius Ou,Jin‐Liern Hong,Petros Christopoulos,Huamao Mark Lin,Sylvie Vincent,Eric N. Churchill,Junpei Soeda,Daniel Kazdal,Albrecht Stenzinger,Michael Thomas	27
5	1231P Characterization and management of mobocertinib (TAK-788) induced skin toxicity in patients with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) who previously received platinum chemotherapy 2021 ·Annals of Oncology ·(unknown),Suresh S. Ramalingam,(unknown),S-W. Kim,Gregory J. Riely,Tarek Mekhail,Danny Nguyen,M.R. García Campelo,Enriqueta Felip,Lyudmila Bazhenova,(unknown),Chandi Griffin,Veronica Bunn,Jonathan B. Lin,Eric N. Churchill,Meenu Mehta,Pasi A. Jänne,C. Zhou	1
6	Mitigation of Radiation-Induced Dermatitis by Activation of Aldehyde Dehydrogenase 2 Using Topical Alda-1 in Mice¹ 2012 ·Radiation Research ·Shoucheng Ning,Grant R. Budas,Eric N. Churchill,Che‐Hong Chen,Susan J. Knox,Daria Mochly‐Rosen	27
7	Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy 2011 ·Journal of Molecular and Cellular Cardiology ·Julio Cesar Batista Ferreira,Tomoyoshi Koyanagi,Suresh S. Palaniyandi,Giovanni Fajardo,Eric N. Churchill,Grant R. Budas,Marie‐Hélène Disatnik,Daniel Bernstein,Patrı́cia C. Brum,Daria Mochly‐Rosen	33
8	The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner 2011 ·Journal of Hematology & Oncology ·(unknown),Eric N. Churchill,(unknown),(unknown),(unknown),Robert T. OʼDonnell,Joseph M. Tuscano	6
9	Mitochondrial import of PKCε is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury 2010 ·Cardiovascular Research ·Grant R. Budas,Eric N. Churchill,Marie‐Hélène Disatnik,Lihan Sun,Daria Mochly‐Rosen	110
10	Non-volume-loaded heart provides a more relevant heterotopic transplantation model 2010 ·Transplant Immunology ·Karis R. Tang-Quan,Jason A. Bartos,T. Deuse,Eric N. Churchill,Hansjörg Schäfer,Hermann Reichenspurner,Daria Mochly‐Rosen,Robert C. Robbins,Sonja Schrepfer	6
11	Ischaemic preconditioning improves proteasomal activity and increases the degradation of PKC during reperfusion 2009 ·Cardiovascular Research ·Eric N. Churchill,Julio Cesar Batista Ferreira,Patrı́cia C. Brum,Luke I. Szweda,Daria Mochly‐Rosen	72
12	Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of ɛPKC and activation of aldehyde dehydrogenase 2 2008 ·Journal of Molecular and Cellular Cardiology ·Eric N. Churchill,Marie‐Hélène Disatnik,Daria Mochly‐Rosen	97
13	Rationally designed peptide regulators of protein kinase C 2008 ·Trends in Endocrinology and Metabolism ·Eric N. Churchill,Nir Qvit,Daria Mochly‐Rosen	85
14	δPKC participates in the endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart 2007 ·Journal of Molecular and Cellular Cardiology ·Xin Qi,Alice Vallentin,Eric N. Churchill,Daria Mochly‐Rosen	57
15	Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic 2007 ·Biochemical Society Transactions ·Grant R. Budas,Tomoyoshi Koyanagi,Eric N. Churchill,Daria Mochly‐Rosen	24
16	PKC Isozymes in Chronic Cardiac Disease: Possible Therapeutic Targets? 2007 ·The Annual Review of Pharmacology and Toxicology ·Eric N. Churchill,Grant R. Budas,Alice Vallentin,Tomoyoshi Koyanagi,Daria Mochly‐Rosen	115
17	Peptides Derived from the C2 Domain of Protein Kinase Cϵ (ϵPKC) Modulate ϵPKC Activity and Identify Potential Protein-Protein Interaction Surfaces 2006 ·Journal of Biological Chemistry ·(unknown),Marie‐Hélène Disatnik,Eric N. Churchill,Daria Mochly‐Rosen	59
18	Translocation of δPKC to mitochondria during cardiac reperfusion enhances superoxide anion production and induces loss in mitochondrial function 2005 ·Archives of Biochemistry and Biophysics ·Eric N. Churchill,Luke I. Szweda	61
19	Reperfusion-Induced Translocation of δPKC to Cardiac Mitochondria Prevents Pyruvate Dehydrogenase Reactivation 2005 ·Circulation Research ·Eric N. Churchill,Christopher L. Murriel,Che-Hong Chen,Daria Mochly‐Rosen,Luke I. Szweda	111
20	Protein Kinase Cδ Activation Induces Apoptosis in Response to Cardiac Ischemia and Reperfusion Damage 2004 ·Journal of Biological Chemistry ·Christopher L. Murriel,Eric N. Churchill,Koichi Inagaki,Luke I. Szweda,Daria Mochly‐Rosen	167

About Eric N. Churchill

Eric N. Churchill is a scholar working on Pathology and Forensic Medicine, Oncology and Biochemistry, having authored 26 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cardiac Ischemia and Reperfusion (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Mitochondrial Function and Pathology (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (637 citations), Biochemistry (140 citations) and Cardiology and Cardiovascular Medicine (363 citations). Eric N. Churchill has collaborated with scholars based in United States, China and Brazil. Frequent co-authors include Daria Mochly‐Rosen, Marie‐Hélène Disatnik, Grant R. Budas, Che-Hong Chen, Thomas D. Hurley, Luke I. Szweda, Christopher L. Murriel, Alice Vallentin, Koichi Inagaki and Tomoyoshi Koyanagi. Their work appears in journals such as Science, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact